InvestorsHub Logo
Followers 14
Posts 389
Boards Moderated 0
Alias Born 01/21/2022

Re: None

Sunday, 04/17/2022 9:22:01 AM

Sunday, April 17, 2022 9:22:01 AM

Post# of 113835
The Seeking Alpha article just published was not paid for by the company or IR. In the article, it is stated that phase one trials have begun at a University of Georgia affiliated hospital for PL4. If this is the case, why can't the company issue a press release? I hope this happens soon.

Also, it mentions again that ADVA 27A is just a variation of a very successful drug called etopocide. People are really missing the boat on this one. This is going to be a very successful cancer drug. The doctor knows exactly how it's going to act in clinical trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News